603368 柳药集团
2026/03 - 三个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)2.8379.18212.00513.50012.276
总资产报酬率 ROA (%)1.0653.3304.1274.3834.069
投入资产回报率 ROIC (%)1.5394.7315.6255.9755.601

边际利润分析
销售毛利率 (%)11.56111.04711.36611.88911.505
营业利润率 (%)5.1294.2174.7385.0154.672
息税前利润/营业总收入 (%)5.8365.1985.8466.2125.829
净利润/营业总收入 (%)4.1933.4434.0964.3563.984

收益指标分析
经营活动净收益/利润总额(%)114.265104.655101.247104.038104.008
价值变动净收益/利润总额(%)0.406-0.006-0.009-0.0680.832
营业外收支净额/利润总额(%)-0.976-1.430-0.046-0.0290.038

偿债能力分析
流动比率 (X)1.6001.5081.5701.4911.489
速动比率 (X)1.2971.2641.3471.2921.262
资产负债率 (%)60.06261.84362.68364.96165.791
带息债务/全部投入资本 (%)42.19643.27047.51952.51452.370
股东权益/带息债务 (%)129.777124.211104.03284.17184.625
股东权益/负债合计 (%)64.02959.32857.18950.53348.760
利息保障倍数 (X)7.7194.9935.2655.1835.044

营运能力分析
应收账款周转天数 (天)180.709180.960178.818165.680151.143
存货周转天数 (天)60.32554.37247.44346.80645.557